Keywords: dor, gets, fda, go, ahead, pivotal, orbec

DOR gets FDA go ahead for pivotal orBec trial

Article | 12 January 2009

Print This

USA-based DOR BioPharma has reached an agreement with the Food and Drug Administration on the design of a confirmatory, pivotal ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in